Ontology of Drug Adverse Events
3920 terms(s) returned
| Term Type: | Record: 501 to 550 of 3920 Records | Page: 11 of 79, First Previous Next Last | Show Records Per Page |
- Decreased Brain Stem Substance P Activity [PE]
- Decreased Capillary Permeability [PE]
- Decreased Cell Membrane Integrity [PE]
- Decreased Cell Membrane Synthesis & Repair [PE]
- Decreased Cell Wall Integrity [PE]
- Decreased Cell Wall Synthesis & Repair [PE]
- Decreased Cellular Migration [PE]
- Decreased Central Nervous System Disorganized Electrical Activity [PE]
- Decreased Central Nervous System Glutamate Activity [PE]
- Decreased Central Nervous System Organized Electrical Activity [PE]
- Decreased Central Nervous System Substance P Activity [PE]
- Decreased Cholesterol Synthesis [PE]
- Decreased Coagulation Activity [PE]
- Decreased Complement Activity [PE]
- Decreased Complement Production [PE]
- Decreased Cytokine Activity [PE]
- Decreased Cytokine Production [PE]
- Decreased DNA Integrity [PE]
- Decreased DNA Replication [PE]
- Decreased Disorganized Electrical Activity [PE]
- Decreased Dopamine Activity [PE]
- Decreased Eicosanoid Activity [PE]
- Decreased Eicosanoid Production [PE]
- Decreased Enteric Nervous System Serotonin Activity [PE]
- Decreased Fibroblast Migration [PE]
- Decreased Folic Acid Modification [PE]
- Decreased Glucocorticoid Secretion [PE]
- Decreased Gluconeogenesis [PE]
- Decreased Glutamate Activity [PE]
- Decreased Glycogenesis [PE]
- Decreased Hematopoiesis [PE]
- Decreased Histamine Activity [PE]
- Decreased Immunologic Activity [PE]
- Decreased Immunologically Active Biogenic Amine Activity [PE]
- Decreased Immunologically Active Biogenic Amine Degradation [PE]
- Decreased Immunologically Active Molecule Activity [PE]
- Decreased Immunologically Active Molecule Degradation [PE]
- Decreased Immunologically Active Molecule Production [PE]
- Decreased Intraocular Aqueous Secretion [PE]
- Decreased Intraocular Fluid Pressure [PE]
- Decreased Intravascular Volume [PE]
- Decreased Iodine Organification [PE]
- Decreased Kinin Activity [PE]
- Decreased Kinin Degradation [PE]
- Decreased Leukotriene Activity [PE]
- Decreased Lipid Derived Immunologically Active Molecule Activity [PE]
- Decreased Lipid Derived Immunologically Active Molecule Production [PE]
- Decreased Luteinizing Hormone Secretion [PE]
- Decreased Lymphocyte Cell Production [PE]
- Decreased Lysosomal Function [PE]
